MediciNova, Inc. (NASDAQ: MNOV) announced that the European Commission has granted Orphan Medicinal Product Designation (OMPD) for MN-166 (ibudilast) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE